TY - JOUR
T1 - A review of guidelines and pharmacologic options for asthma treatment, with a focus on exercise-induced bronchoconstriction.
AU - Spangler, Mikayla
AU - Hawley, Heather
AU - Barnes, Nicole
AU - Saxena, Shailendra
PY - 2013/9
Y1 - 2013/9
N2 - Asthma affects millions of individuals worldwide. Exercise-induced bronchoconstriction is common in patients diagnosed with asthma, but may also occur in patients without chronic asthma. Patients with isolated exercise-induced bronchoconstriction may require pretreatment with inhaled short-acting β-agonists prior to exercise. Patients diagnosed with asthma can achieve good control of the symptoms of exercise-induced bronchoconstriction with appropriate treatment of underlying chronic asthma. Current guidelines suggest staging patients with asthma based on severity of symptoms and initiating therapy according to their stage. Pharmacotherapy for asthma management consists of both quick-relief medications (short-acting β-agonists) as well as maintenance, or long-term control, medications (inhaled corticosteroids, long-acting β-agonists, leukotriene receptor antagonists, cromolyn, and theophylline).
AB - Asthma affects millions of individuals worldwide. Exercise-induced bronchoconstriction is common in patients diagnosed with asthma, but may also occur in patients without chronic asthma. Patients with isolated exercise-induced bronchoconstriction may require pretreatment with inhaled short-acting β-agonists prior to exercise. Patients diagnosed with asthma can achieve good control of the symptoms of exercise-induced bronchoconstriction with appropriate treatment of underlying chronic asthma. Current guidelines suggest staging patients with asthma based on severity of symptoms and initiating therapy according to their stage. Pharmacotherapy for asthma management consists of both quick-relief medications (short-acting β-agonists) as well as maintenance, or long-term control, medications (inhaled corticosteroids, long-acting β-agonists, leukotriene receptor antagonists, cromolyn, and theophylline).
UR - http://www.scopus.com/inward/record.url?scp=84891530604&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84891530604&partnerID=8YFLogxK
U2 - 10.3810/psm.2013.09.2024
DO - 10.3810/psm.2013.09.2024
M3 - Review article
C2 - 24113702
AN - SCOPUS:84891530604
VL - 41
SP - 50
EP - 57
JO - Physician and Sportsmedicine
JF - Physician and Sportsmedicine
SN - 0091-3847
IS - 3
ER -